Companies / Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc.
FUSNCIK 1805890
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| When | What happened | Size | Change in position | Impact |
|---|---|---|---|---|
| Feb 16, 2022 | CEO · Open-market sale · Common Stock | $265.3K 33,202 sh @ $8 | -6.39% · a meaningful trim 519K → 486K sh | medium |
| Feb 23, 2022 | CEO · Open-market sale · Common Stock | $227.7K 29,299 sh @ $8 | -6.16% · a meaningful trim 475K → 446K sh | medium |
| Mar 2, 2022 | CEO · Open-market sale · Common Stock | $197.5K 26,546 sh @ $7 | -6.15% · a meaningful trim 432K → 405K sh | medium |
| Apr 12, 2022 | CEO · Open-market sale · Common Stock | $129.6K 18,255 sh @ $7 | -5.09% · a meaningful trim 358K → 340K sh | medium |
| Feb 15, 2022 | CEO · Open-market sale · Common Stock | $105.0K 12,600 sh @ $8 | -2.37% · a slight trim 532K → 519K sh | medium |
| Nov 11, 2022 | Khuong Chau Quang was granted Director · Grant or award · Common Stock | $100.2K 42,093 sh @ $2 | ▲ New position · none held before now 42K sh | low |
| Aug 11, 2022 | Gannon Steven bought Director · Open-market buy · Common Stock | $90.1K 44,400 sh @ $2 | +370.00% · more than tripled it 12K → 56K sh | medium |
| Apr 13, 2022 | CEO · Open-market sale · Common Stock | $76.9K 11,994 sh @ $6 | -3.53% · a slight trim 340K → 328K sh | low |